Our previous studies, as well as studies from Ono’s group, have demonstrated that overexpression of CTMP can induce Akt phosphorylation, leading to increased Akt activity and facilitating apoptosis evasion, glucose metabolism, and breast cancer progression [16–18]. This evidence concerns the gene AKT1 and breast carcinoma.